- Isocitrate dehydrogenase 2 inhibitor enasidenib synergizes daunorubicin cytotoxicity by targeting aldo-keto reductase 1C3 and ATP-binding cassette transporters2022 | Faculty of Pharmacy in Hradec Králové
- Interconversion between Tumorigenic and Differentiated States in Acute Myeloid Leukemia2019 | First Faculty of Medicine
